jama naion semaglutide Linked to Risk Do GLP-1 Medications Cause Eye

Durable coexistence of donor and recipient strains after fecal microbiota transplantation

In January, a paper in JAMA Ophthalmology reported nine cases of people who experienced eye problems while taking GLP-1 drugs - six on semaglutide and three on tirzepatide

A pivotal 2021 clinical study of more than 1,900 adults, known as the STEP 1 trial, laid the groundwork for the use of these drugs as a treatment for weight loss

Who is eligible for Semaglutide GLP1 weight loss therapy

Increasing awareness programs have improved diagnosis rates by 29%, strengthening the regions role in the Liraglutide and Semaglutide Market Insights